MediClin AG (XTER:MED) Cyclically Adjusted PS Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:MED MediClin AG XTER:MED
68 GF Score
Price €5.50
GF Value €3.21
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is MediClin AG Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


MediClin AG  (XTER:MED) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


MediClin AG Cyclically Adjusted PS Ratio Related Terms


MediClin AG Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for MediClin AG's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MediClin AG Cyclically Adjusted PS Ratio Chart

MediClin AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.29 0.24 0.18 0.15 0.23

MediClin AG Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.19 0.22 0.20 0.24

XTER:MED vs HCA, THC, EHC: Cyclically Adjusted PS Ratio Comparison

For the Medical Care Facilities subindustry, MediClin AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MediClin AG Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MediClin AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where MediClin AG's Cyclically Adjusted PS Ratio falls into.


XTER:MED
68GF Score
MediClin AG XTER:MED
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MediClin AG Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

MediClin AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, MediClin AG's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=4.2/131.3638*131.3638
=4.200

Current CPI (Jun. 2026) = 131.3638.

MediClin AG Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 3.074 101.017 3.997
201612 3.056 101.217 3.966
201703 3.097 101.417 4.011
201706 3.197 102.117 4.113
201709 3.234 102.717 4.136
201712 3.296 102.617 4.219
201803 3.320 102.917 4.238
201806 3.442 104.017 4.347
201809 3.447 104.718 4.324
201812 3.367 104.217 4.244
201903 3.529 104.217 4.448
201906 3.533 105.718 4.390
201909 3.565 106.018 4.417
201912 3.545 105.818 4.401
202003 3.525 105.718 4.380
202006 3.287 106.618 4.050
202009 3.688 105.818 4.578
202012 3.393 105.518 4.224
202103 3.292 107.518 4.022
202106 3.511 108.486 4.251
202109 3.683 109.435 4.421
202112 3.686 110.384 4.387
202203 3.668 113.968 4.228
202206 3.813 115.760 4.327
202209 3.600 118.818 3.980
202212 3.755 119.345 4.133
202303 3.720 122.402 3.992
202306 3.960 123.140 4.224
202309 3.839 124.195 4.061
202312 3.851 123.773 4.087
202403 3.904 125.038 4.102
202406 3.843 125.882 4.010
202409 4.005 126.198 4.169
202412 4.011 127.041 4.147
202503 3.724 127.779 3.828
202506 4.026 128.412 4.119
202509 4.276 129.255 4.346
202512 4.159 129.361 4.223
202603 3.934 131.258 3.937
202606 4.200 131.364 4.200

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is MediClin AG (XTER:MED) Overvalued in 2026?

Based on GuruFocus' analysis, MediClin AG stock appears to be overvalued. The current stock price of €5.50 is trading 71.3% above its estimated GF Value™ of €3.21. GuruFocus considers MediClin AG to be Significantly Overvalued.

Key valuation signals for XTER:MED:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €3.21 vs. price of €5.50 (71.3% above fair value)
  • GF Score™: 68/100 with 6 warning signs

No single metric tells the full story. See the XTER:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MediClin AG Business Description

Other Exchanges 0NDG:UK
Address Okenstrasse 27, Offenburg, BW, DEU, 77652
MediClin AG operates hospitals and other medical care centers. The company's reportable operating segments are the Post-acute, Acute, Nursing care, and Service segments. A majority of its revenue is generated from the Post-acute segment, which offers services in the fields of follow-up rehabilitation treatment and curative treatment. Some of the post-acute hospitals also offer services in acute neurology and acute psychosomatics. The Acute segment encompasses medical offerings with a focus on neurology and neurological early rehabilitation as well as psychosomatic medicine, psychiatry, orthopaedics, and internal medicine. The Nursing care segment offers full-time and part-time nursing care as well as daycare, and the Service segment consists of the central services.
68GF Score

Get the complete analysis for XTER:MED

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.50
Price
€3.21
GF Value